A
Amy P. Abernethy
Researcher at Duke University
Publications - 586
Citations - 29463
Amy P. Abernethy is an academic researcher from Duke University. The author has contributed to research in topics: Palliative care & Population. The author has an hindex of 76, co-authored 586 publications receiving 25420 citations. Previous affiliations of Amy P. Abernethy include University of Technology, Sydney & Johns Hopkins University School of Medicine.
Papers
More filters
Peer-reviewed Articles Abstracted for Literature Review
Amy P. Abernethy,Nancy M Allen Lapointe,Jane L. Wheeler,R Julian Irvine,Meenal Patwardhan,David B. Matchar +5 more
Journal ArticleDOI
Probiotics to Prevent Antibiotic-Related Diarrhea
TL;DR: Primary outcome was occurrence of diarrhea using daily probiotic yogurt drink, and the intervention began less than 48 hours after starting antibiotics and continued for one week after discontinuing antibiotics.
Journal ArticleDOI
Oncologists’ perceptions of rounding alongside palliative care physicians: Results of a post-intervention survey study.
Thomas W. LeBlanc,James A. Tulsky,Amy P. Abernethy,Christopher A Jones,Anthony N. Galanos,Richard F. Riedel +5 more
TL;DR: A new rounding model was instituted on the inpatient solid tumor oncology service at Duke in August 2011 that incorporated a palliative care physician as a second attending on service, alongside the rounding solid tumors oncologist.
Journal ArticleDOI
What's in the Palliative Care Syringe?: Association Between Specific Palliative Care Interventions and Improvement in Quality of Life (TH330-B)
Journal ArticleDOI
Outcomes of “real world” treatment for metastatic renal cell carcinoma (mRCC).
Michael R. Harrison,Daniel J. George,Mark S. Walker,Lori L. Hudson,Connie Chen,Beata Korytowsky,Edward J. Stepanski,Amy P. Abernethy +7 more
TL;DR: In the real world setting pts receiving mTOR as the 1st treatment exposure had worse OS, likely because pts with more aggressive disease were preferentially treated with mTOR, which requires further evaluation.